sotalol has been researched along with Addiction, Opioid in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sotalol hydrochloride was selected as a model drug." | 1.43 | Assessing impact of formulation and process variables on in-vitro performance of directly compressed abuse deterrent formulations. ( Ashraf, M; Khan, MA; Korang-Yeboah, M; Rahman, Z; Siddiqui, A; Xu, X; Yang, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rahman, Z | 1 |
| Yang, Y | 1 |
| Korang-Yeboah, M | 1 |
| Siddiqui, A | 1 |
| Xu, X | 1 |
| Ashraf, M | 1 |
| Khan, MA | 1 |
1 other study available for sotalol and Addiction, Opioid
| Article | Year |
|---|---|
Assessing impact of formulation and process variables on in-vitro performance of directly compressed abuse deterrent formulations.
Topics: Chemistry, Pharmaceutical; Dosage Forms; Drug Compounding; Hardness; Opioid-Related Disorders; Parti | 2016 |